In the current study, we focused on the relative importance of an oncogenic mutation in KRAS (G12D) and deletion of p53 in macropinocytosis and ferroptosis in colon cancer using isogenic cancer cell lines with and without the KRAS mutation as well as with and without p53. This evidence concerns the gene TP53 and colonic neoplasm.